Biomarker for steatohepatitis (fatty liver disease) identified

Steatohepatitis (fatty liver disease) is a disease that is becoming increasingly more frequent as a result of diabetes and excess weight in an affluent society. Currently, it is not possible to forecast the further course of the disease – right up to cirrhosis and cancer of the liver — but …read more

We suggest you read  Medtronic, Covidien chief integration officer talks about what the deal means